<DOC>
	<DOCNO>NCT00682344</DOCNO>
	<brief_summary>Levobupivacaïne ( Chirocaine® ) new local anaesthetic recently market France . The goal prospective work study pharmacokinetic aspect drug injection around sciatic nerve ( subgluteal way ) .</brief_summary>
	<brief_title>Pharmacokinetic levobupivacaïne After Sciatic Nerve Block Children</brief_title>
	<detailed_description>The originality work call upon model pharmacokinetic use principle pharmacology population . This work also propose appreciate dynamic aspect since data effectiveness tolerance collect regular interval first 24 hour begin study .</detailed_description>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Surgical pathology leg foot garot tyre thigh Age include 6 month 12 year Status ASA I II Bilateral onesided surgical gesture realize without garot tyre Cutaneous infection point drain Clinical confusion coagulation Allergy inform local anesthesics aminoacid class Evolutionary neurological pathology operate limb Renal , respiratory , cardiac hepatic insufficiency .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>